Surgical excision plays a central role in managing angiosarcoma, though prognosis remains poor, highlighting the need for novel therapies for metastatic disease.
Our large single institution series confirms the poor prognosis of angiosarcoma, supports a central role for surgical excision in management, and highlights the need for novel therapies particularly in patients who present with metastatic disease.
Buehler et al. (Thu,) studied this question.